Jiangsu Ascentage Biomed Development Inc. – Trademark Portfolio
Entity Type: 03
Jiangsu Ascentage Biomed Development Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ASCENTAGE PHARMA. The owner is based in Taizhou, Jiangsu.
Rm 101, 1st Flr, Phase 1, New Drug Innov
No. 1 Medical City Ave
Taizhou, Jiangsu 225300 , CN
Showing of trademarks Trademarks
Trademark Classifications
Jiangsu Ascentage Biomed Development Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Jiangsu Ascentage Biomed Development Inc. have?
Jiangsu Ascentage Biomed Development Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Jiangsu Ascentage Biomed Development Inc. file in?
Jiangsu Ascentage Biomed Development Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Jiangsu Ascentage Biomed Development Inc.'s most well-known trademarks?
Jiangsu Ascentage Biomed Development Inc.'s registered trademark portfolio includes well-known marks such as ASCENTAGE PHARMA. These are among 2 currently registered trademarks in the portfolio.
What is Jiangsu Ascentage Biomed Development Inc.'s trademark registration success rate?
Jiangsu Ascentage Biomed Development Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.